Developed by CAC Engineering, Bondalti Chemicals’ facility made use of Asahi Kasei’s chlor-alkali electrolysis technology. The new unit will also be utilized for further reducing power consumption and optimizing the use of materials in the chlor-alkali industry.

BASF has unveiled its new production line for water-based dispersions in Heerenveen, the Netherlands. With this new line, the company will be able to increase its production capacity without additional CO2 emissions.

Wood has been assigned to provide project management consultancy services for Turkey’s largest polypropylene plant and associated terminal facility. On completion, the plant is expected to produce 472,500 tons of polypropylene annually.

With a mega 10-million-euro investment, IFF has expanded its LMR Naturals site in Grasse, France. With this move, the company brings together more than 30 research and development experts under one roof, enhancing the firm’s ability to meet the growing global demand for traceable, sustainable and high-quality naturals.

The “Best CO2 Utilisation 2025” innovation award was presented at the international CCU conference in Cologne. Three technologies were honored for converting CO2 into high-quality products such as graphite, polyurethanes, and methanol, thereby making a decisive contribution to industrial decarbonization.

Under a MOU signed between Merck and Siemens, both the companies will extend their partnership in order to accelerate digital transformation in the life science industry. The MOU focuses on delivering integrated software solutions, systems and consumables that harness automation, data and AI to connect drug discovery, development, and manufacturing.

Schubert has expanded its ‘4You Service’ portfolio and now offers its customers measurable benefits in terms of efficiency, availability and sustainability – both in analogue and digital form.

Roche has recently signed a definitive merger agreement to acquire 89bio, a clinical-stage biopharma firm specializing in the development of innovative therapies for the treatment of liver and cardiometabolic diseases.

With a mega investment of 6.5 billion dollars, Eli Lilly and Company has plans to develop a next-generation synthetic medicine active pharmaceutical product facility in Texas, USA. The facility will focus on manufacturing the company's pipeline of small molecule medicines across therapeutic areas.

Husky Technologies is showcasing its latest innovations in sustainable beverage packaging at Drinktec 2025, one of the leading trade shows for the beverage and liquid food industry, which is taking place from September 15 -19 in Munich, Germany.